Revdex.com: I have reviewed the response made by the business in reference to complaint ID [redacted] , and find that this resolution is somewhat satisfactory to me They have delayed this for so long that I now only will get one refill Way to go, Astra Zeneca! Regards,
I am the Senior Manager, Patient Assistance Programs at AstraZeneca Iam writing in response to the concerns of [redacted] , which were submitted to the Revdex.com Serving Delaware on 6/23/and received by AstraZeneca on 6/26/15.In her complaint to the Revdex.com, Ms [redacted] stated that she initiated an application with the AZ&Me Prescription Savings Program on 2/Ms [redacted] states that she made several callattempts to our program administrator to check on the status of her application/prescription and each time she received conflicting information regarding what was needed to finalize her applicationThe program adm;nistrator's records show that the patient completed a pre-screened application on 219/15, but additional information was neededOn 2/10/a pre-populated application was mailed to the patientas well as a notification a prescription and proof of income were needed for enrollmentOn 2127/the program administrator received the application back, but the prescription was not filled out and there was no proof of income with her documentsOn 3/a letter was sent to the patient notifying her that we needed her Healthcare professional information to proceed with her applicationOn 5/11/an inactive not\ce was sent to the patient to notify her that her temporary enrollment had ended because the additional information that was previously requested had not been receivedOn the patient called the program administrator to notify them she was contacting her heafth care professional for a new prescriptionOn 6/8/the prescription was received, but there was no indication of which health care professional signed the prescription and no proof of income was includedOn 7/1/all outstanding documents were received and the patient has received her prescription.Ms [redacted] has been fully enrolled in the AZ&Me Prescription Savings Program and is eligible to receive her medication for free through the program until 12131/15, per the rules of the programMs [redacted] will need to complete the program re-enrollment process in order to continue receiving this medication from the program in 2016.If you require any additional information regarding this case, please do not hesitate to contact me
Response: The message below was sent to the Revdex.com via fax on June 2, 2017: RE: Case ID [redacted] Attn: [redacted] I am the Senior Manager, Patient Assistance Programs at AstraZenecaI am writing in response to the concerns of one of our patients (Case # [redacted] ), which were submitted to the Revdex.com Serving Delaware on 3/28/and received by AstraZeneca on 5/15/In the complaint to the Revdex.com, the patient stated that he has applied several times for the AZ&Me Prescription Savings Program for assistance with medication and that he was denied each time due to an error on his applicationThe patient stated that this issue had been going on for several monthsUnder the AZ&Me Prescription Savings Program, eligible individuals who are either uninsured or are insured with Medicare Parts B or D can receive their medication at no costA review of the interactions between this patient and our program administration vendor shows that the patient applied several times for the program between July and March Our program rules allow for patients who meet the program eligibility requirements, based on their initial applications, to be temporarily enrolled in the program and provided with up to a 30-day supply of medicationPatients are advised that, to be fully enrolled in the program, they must submit proof of income documentationThe patient was granted temporary enrollment in the program and received three separate 30-day supplies of his medication from the AZ&Me program at no costThe patient was advised, both via mail and during several phone calls (most recently on 3/30/17), that he must submit proof of income to be fully enrolled in the programOn 4/4/17, AstraZeneca notified the patient by mail that the medication requested by the patient would be removed from the AZ&Me Prescription Savings Program effective 6/30/The letter advised the patient of other resources for prescription assistance, including RxOutreachIf you require any additional information regarding this case, please do not hesitate to contact meSincerely, [redacted] Senior Manager, Patient Assistance Programs [redacted]
I am the Senior Manager, Patient Assistance Programs at AstraZeneca. Iam writing in response to the concerns of [redacted], which were submitted to the Revdex.com Serving Delaware on 6/23/15 and received by AstraZeneca on 6/26/15.In her complaint to the Revdex.com, Ms. [redacted] stated...
that she initiated an application with the AZ&Me Prescription Savings Program on 2/2115. Ms. [redacted] states that she made several callattempts to our program administrator to check on the status of her application/prescription and each time she received conflicting information regarding what was needed to finalize her application. The program adm;nistrator's records show that the patient completed a pre-screened application on 219/15, but additional information was needed. On 2/10/2015 a pre-populated application was mailed to the patientas well as a notification a prescription and proof of income were needed for enrollment. On 2127/15 the program administrator received the application back, but the prescription was not filled out and there was no proof of income with her documents. On 3/2115 a letter was sent to the patient notifying her that we needed her Healthcare professional information to proceed with her application. On 5/11/15 an inactive not\ce was sent to the patient to notify her that her temporary enrollment had ended because the additional information that was previously requested had not been received. On 612115 the patient called the program administrator to notify them she was contacting her heafth care professional for a new prescription. On 6/8/15 the prescription was received, but there was no indication of which health care professional signed the prescription and no proof of income was included. On 7/1/15 all outstanding documents were received and the patient has received her prescription.Ms. [redacted] has been fully enrolled in the AZ&Me Prescription Savings Program and is eligible to receive her medication for free through the program until 12131/15, per the rules of the program. Ms. [redacted] will need to complete the program re-enrollment process in order to continue receiving this medication from the program in 2016.If you require any additional information regarding this case, please do not hesitate to contact me.
Revdex.com:
I have reviewed the response made by the business in reference to complaint ID [redacted], and find that this resolution is somewhat satisfactory to me. They have delayed this for so long that I now only will get one refill. Way to go, Astra Zeneca!
Regards,
Response: The message below was sent to the Revdex.com via fax on June 2, 2017: RE: Case ID [redacted] Attn: [redacted] I am the Senior Manager, Patient Assistance Programs at AstraZeneca. I am writing in response to the concerns of one of our patients (Case #[redacted]), which were...
submitted to the Revdex.com Serving Delaware on 3/28/17 and received by AstraZeneca on 5/15/17. In the complaint to the Revdex.com, the patient stated that he has applied several times for the AZ&Me Prescription Savings Program for assistance with medication and that he was denied each time due to an error on his application. The patient stated that this issue had been going on for several months. Under the AZ&Me Prescription Savings Program, eligible individuals who are either uninsured or are insured with Medicare Parts B or D can receive their medication at no cost. A review of the interactions between this patient and our program administration vendor shows that the patient applied several times for the program between July 2016 and March 2017. Our program rules allow for patients who meet the program eligibility requirements, based on their initial applications, to be temporarily enrolled in the program and provided with up to a 30-day supply of medication. Patients are advised that, to be fully enrolled in the program, they must submit proof of income documentation. The patient was granted temporary enrollment in the program and received three separate 30-day supplies of his medication from the AZ&Me program at no cost. The patient was advised, both via mail and during several phone calls (most recently on 3/30/17), that he must submit proof of income to be fully enrolled in the program. On 4/4/17, AstraZeneca notified the patient by mail that the medication requested by the patient would be removed from the AZ&Me Prescription Savings Program effective 6/30/17. The letter advised the patient of other resources for prescription assistance, including RxOutreach. If you require any additional information regarding this case, please do not hesitate to contact me. Sincerely, [redacted] Senior Manager, Patient Assistance Programs [redacted]
Revdex.com: I have reviewed the response made by the business in reference to complaint ID [redacted] , and find that this resolution is somewhat satisfactory to me They have delayed this for so long that I now only will get one refill Way to go, Astra Zeneca! Regards,
I am the Senior Manager, Patient Assistance Programs at AstraZeneca Iam writing in response to the concerns of [redacted] , which were submitted to the Revdex.com Serving Delaware on 6/23/and received by AstraZeneca on 6/26/15.In her complaint to the Revdex.com, Ms [redacted] stated that she initiated an application with the AZ&Me Prescription Savings Program on 2/Ms [redacted] states that she made several callattempts to our program administrator to check on the status of her application/prescription and each time she received conflicting information regarding what was needed to finalize her applicationThe program adm;nistrator's records show that the patient completed a pre-screened application on 219/15, but additional information was neededOn 2/10/a pre-populated application was mailed to the patientas well as a notification a prescription and proof of income were needed for enrollmentOn 2127/the program administrator received the application back, but the prescription was not filled out and there was no proof of income with her documentsOn 3/a letter was sent to the patient notifying her that we needed her Healthcare professional information to proceed with her applicationOn 5/11/an inactive not\ce was sent to the patient to notify her that her temporary enrollment had ended because the additional information that was previously requested had not been receivedOn the patient called the program administrator to notify them she was contacting her heafth care professional for a new prescriptionOn 6/8/the prescription was received, but there was no indication of which health care professional signed the prescription and no proof of income was includedOn 7/1/all outstanding documents were received and the patient has received her prescription.Ms [redacted] has been fully enrolled in the AZ&Me Prescription Savings Program and is eligible to receive her medication for free through the program until 12131/15, per the rules of the programMs [redacted] will need to complete the program re-enrollment process in order to continue receiving this medication from the program in 2016.If you require any additional information regarding this case, please do not hesitate to contact me
Response: The message below was sent to the Revdex.com via fax on June 2, 2017: RE: Case ID [redacted] Attn: [redacted] I am the Senior Manager, Patient Assistance Programs at AstraZenecaI am writing in response to the concerns of one of our patients (Case # [redacted] ), which were submitted to the Revdex.com Serving Delaware on 3/28/and received by AstraZeneca on 5/15/In the complaint to the Revdex.com, the patient stated that he has applied several times for the AZ&Me Prescription Savings Program for assistance with medication and that he was denied each time due to an error on his applicationThe patient stated that this issue had been going on for several monthsUnder the AZ&Me Prescription Savings Program, eligible individuals who are either uninsured or are insured with Medicare Parts B or D can receive their medication at no costA review of the interactions between this patient and our program administration vendor shows that the patient applied several times for the program between July and March Our program rules allow for patients who meet the program eligibility requirements, based on their initial applications, to be temporarily enrolled in the program and provided with up to a 30-day supply of medicationPatients are advised that, to be fully enrolled in the program, they must submit proof of income documentationThe patient was granted temporary enrollment in the program and received three separate 30-day supplies of his medication from the AZ&Me program at no costThe patient was advised, both via mail and during several phone calls (most recently on 3/30/17), that he must submit proof of income to be fully enrolled in the programOn 4/4/17, AstraZeneca notified the patient by mail that the medication requested by the patient would be removed from the AZ&Me Prescription Savings Program effective 6/30/The letter advised the patient of other resources for prescription assistance, including RxOutreachIf you require any additional information regarding this case, please do not hesitate to contact meSincerely, [redacted] Senior Manager, Patient Assistance Programs [redacted]
I am the Senior Manager, Patient Assistance Programs at AstraZeneca. Iam writing in response to the concerns of [redacted], which were submitted to the Revdex.com Serving Delaware on 6/23/15 and received by AstraZeneca on 6/26/15.In her complaint to the Revdex.com, Ms. [redacted] stated...
that she initiated an application with the AZ&Me Prescription Savings Program on 2/2115. Ms. [redacted] states that she made several callattempts to our program administrator to check on the status of her application/prescription and each time she received conflicting information regarding what was needed to finalize her application. The program adm;nistrator's records show that the patient completed a pre-screened application on 219/15, but additional information was needed. On 2/10/2015 a pre-populated application was mailed to the patientas well as a notification a prescription and proof of income were needed for enrollment. On 2127/15 the program administrator received the application back, but the prescription was not filled out and there was no proof of income with her documents. On 3/2115 a letter was sent to the patient notifying her that we needed her Healthcare professional information to proceed with her application. On 5/11/15 an inactive not\ce was sent to the patient to notify her that her temporary enrollment had ended because the additional information that was previously requested had not been received. On 612115 the patient called the program administrator to notify them she was contacting her heafth care professional for a new prescription. On 6/8/15 the prescription was received, but there was no indication of which health care professional signed the prescription and no proof of income was included. On 7/1/15 all outstanding documents were received and the patient has received her prescription.Ms. [redacted] has been fully enrolled in the AZ&Me Prescription Savings Program and is eligible to receive her medication for free through the program until 12131/15, per the rules of the program. Ms. [redacted] will need to complete the program re-enrollment process in order to continue receiving this medication from the program in 2016.If you require any additional information regarding this case, please do not hesitate to contact me.
Revdex.com:
I have reviewed the response made by the business in reference to complaint ID [redacted], and find that this resolution is somewhat satisfactory to me. They have delayed this for so long that I now only will get one refill. Way to go, Astra Zeneca!
Regards,
Response: The message below was sent to the Revdex.com via fax on June 2, 2017: RE: Case ID [redacted] Attn: [redacted] I am the Senior Manager, Patient Assistance Programs at AstraZeneca. I am writing in response to the concerns of one of our patients (Case #[redacted]), which were...
submitted to the Revdex.com Serving Delaware on 3/28/17 and received by AstraZeneca on 5/15/17. In the complaint to the Revdex.com, the patient stated that he has applied several times for the AZ&Me Prescription Savings Program for assistance with medication and that he was denied each time due to an error on his application. The patient stated that this issue had been going on for several months. Under the AZ&Me Prescription Savings Program, eligible individuals who are either uninsured or are insured with Medicare Parts B or D can receive their medication at no cost. A review of the interactions between this patient and our program administration vendor shows that the patient applied several times for the program between July 2016 and March 2017. Our program rules allow for patients who meet the program eligibility requirements, based on their initial applications, to be temporarily enrolled in the program and provided with up to a 30-day supply of medication. Patients are advised that, to be fully enrolled in the program, they must submit proof of income documentation. The patient was granted temporary enrollment in the program and received three separate 30-day supplies of his medication from the AZ&Me program at no cost. The patient was advised, both via mail and during several phone calls (most recently on 3/30/17), that he must submit proof of income to be fully enrolled in the program. On 4/4/17, AstraZeneca notified the patient by mail that the medication requested by the patient would be removed from the AZ&Me Prescription Savings Program effective 6/30/17. The letter advised the patient of other resources for prescription assistance, including RxOutreach. If you require any additional information regarding this case, please do not hesitate to contact me. Sincerely, [redacted] Senior Manager, Patient Assistance Programs [redacted]